361 related articles for article (PubMed ID: 15251111)
21. The efficacy of bovine lactoferrin in the treatment of cows with experimentally induced Escherichia coli mastitis.
Kutila T; Suojala L; Lehtolainen T; Saloniemi H; Kaartinen L; Tähti M; Seppälä K; Pyörälä S
J Vet Pharmacol Ther; 2004 Aug; 27(4):197-202. PubMed ID: 15305847
[TBL] [Abstract][Full Text] [Related]
22. Analysis of protective mechanisms against infection by Serratia marcescens.
Okada K
J Clin Lab Immunol; 1985 Apr; 16(4):183-90. PubMed ID: 3894671
[TBL] [Abstract][Full Text] [Related]
23. Comparison of amikacin dosing regimens in neutropenic guinea pigs with Escherichia coli infection.
McClure JT; Rosin E
Am J Vet Res; 1998 Jun; 59(6):750-5. PubMed ID: 9622746
[TBL] [Abstract][Full Text] [Related]
24. Synergism in immunotoxicological effects due to repeated combined administration of arsenic and lead in mice.
Bishayi B; Sengupta M
Int Immunopharmacol; 2006 Mar; 6(3):454-64. PubMed ID: 16428081
[TBL] [Abstract][Full Text] [Related]
25. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
26. Bovine lactoferrin decreases histopathological changes in the liver and regulates cytokine production by splenocytes of obstructive jaundiced rats.
Zimecki M; Dawiskiba J; Zawirska B; Krawczyk Z; Kruzel M
Inflamm Res; 2003 Jun; 52(7):305-10. PubMed ID: 12861396
[TBL] [Abstract][Full Text] [Related]
27. Effect of lactoferrin on lipopolysaccharide (LPS) induced preterm delivery in mice.
Mitsuhashi Y; Otsuki K; Yoda A; Shimizu Y; Saito H; Yanaihara T
Acta Obstet Gynecol Scand; 2000 May; 79(5):355-8. PubMed ID: 10830761
[TBL] [Abstract][Full Text] [Related]
28. Role of macrophages in a mouse model of postoperative MRSA enteritis.
Tanaka H; Miyazaki S; Sumiyama Y; Kakiuchi T
J Surg Res; 2004 May; 118(2):114-21. PubMed ID: 15100000
[TBL] [Abstract][Full Text] [Related]
29. Antisense peptide-phosphorodiamidate morpholino oligomer conjugate: dose-response in mice infected with Escherichia coli.
Tilley LD; Mellbye BL; Puckett SE; Iversen PL; Geller BL
J Antimicrob Chemother; 2007 Jan; 59(1):66-73. PubMed ID: 17079242
[TBL] [Abstract][Full Text] [Related]
30. Influence of orally administered bovine lactoferrin on lipid metabolism in lipopolysaccharide-injected preruminant calves.
Kushibiki S; Shingu H; Komatsu T; Itoh F; Moriya N; Touno E; Oshibe A; Hodate K
Anim Sci J; 2009 Jun; 80(3):258-64. PubMed ID: 20163633
[TBL] [Abstract][Full Text] [Related]
31. Radiation and primary response to lipopolysaccharide: bone marrow-derived cells and susceptible organs.
Gridley DS; Miller GM; Pecaut MJ
In Vivo; 2007; 21(3):453-61. PubMed ID: 17591354
[TBL] [Abstract][Full Text] [Related]
32. [Immunosuppressive effect of cyclophosphamide in experimental coagulase-negative staphylococcal infection].
Nagy G; Pappné FE; Kovács P; Sztroj T; Rozgonyi F
Orv Hetil; 1993 May; 134(20):1077-81. PubMed ID: 8497387
[TBL] [Abstract][Full Text] [Related]
33. Lactoferrin effects on phagocytic cell function. I. Increased uptake and killing of an intracellular parasite by murine macrophages and human monocytes.
Lima MF; Kierszenbaum F
J Immunol; 1985 Jun; 134(6):4176-83. PubMed ID: 3886800
[TBL] [Abstract][Full Text] [Related]
34. Enhanced Th1 response to Staphylococcus aureus infection in human lactoferrin-transgenic mice.
Guillén C; McInnes IB; Vaughan DM; Kommajosyula S; Van Berkel PH; Leung BP; Aguila A; Brock JH
J Immunol; 2002 Apr; 168(8):3950-7. PubMed ID: 11937551
[TBL] [Abstract][Full Text] [Related]
35. Lysostaphin as a treatment for systemic Staphylococcus aureus infection in a mouse model.
Kokai-Kun JF; Chanturiya T; Mond JJ
J Antimicrob Chemother; 2007 Nov; 60(5):1051-9. PubMed ID: 17848374
[TBL] [Abstract][Full Text] [Related]
36. Ganoderma lucidum polysaccharides enhance the function of immunological effector cells in immunosuppressed mice.
Zhu XL; Chen AF; Lin ZB
J Ethnopharmacol; 2007 May; 111(2):219-26. PubMed ID: 17182202
[TBL] [Abstract][Full Text] [Related]
37. Lactoferrin: an iron-binding antimicrobial protein against Escherichia coli infection.
Yen CC; Shen CJ; Hsu WH; Chang YH; Lin HT; Chen HL; Chen CM
Biometals; 2011 Aug; 24(4):585-94. PubMed ID: 21327478
[TBL] [Abstract][Full Text] [Related]
38. RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis.
Ghiselli R; Giacometti A; Cirioni O; Dell'Acqua G; Bergnach C; Orlando F; Mocchegiani F; Silvestri C; Skerlavaj B; Licci A; Balaban N; Zanetti M; Scalise G; Saba V
Shock; 2006 Sep; 26(3):296-301. PubMed ID: 16912656
[TBL] [Abstract][Full Text] [Related]
39. Effect of bovine lactoferrin in Salmonella ser. Typhimurium infection in mice.
Mosquito S; Ochoa TJ; Cok J; Cleary TG
Biometals; 2010 Jun; 23(3):515-21. PubMed ID: 20306285
[TBL] [Abstract][Full Text] [Related]
40. [Characteristics of the increased resistance of mice to Pseudomonas aeruginosa caused by Staphylococcus aureus].
Mathieu LG; deRepentigny J; Gadbois T
Can J Microbiol; 1976 Dec; 22(12):1734-42. PubMed ID: 827329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
